human
metapneumoviru
hmpv
emerg
caus
sever
respiratori
tract
infect
immunocompromis
patient
hmpv
pneumonia
seldom
report
nonpulmonari
solid
organ
transplant
patient
renal
transplant
recipi
report
case
patient
present
fever
cough
interstiti
opac
ct
scan
diagnos
nonsever
hmpv
pneumonia
year
renal
transplant
infect
resolv
spontan
differenti
diagnosi
pneumocysti
pneumonia
discuss
review
medic
literatur
discuss
clinic
present
detect
method
propos
solid
organ
transplant
recipi
respiratori
virus
respiratori
syncyti
viru
rsv
influenza
parainfluenza
virus
piv
adenoviru
commonli
associ
mild
sever
symptom
depend
immun
statu
human
metapneumoviru
hmpv
sixth
frequent
viral
infect
patient
hospit
respiratori
ill
hmpv
nonseg
envelop
neg
singlestrand
rna
viru
respons
lower
respiratori
tract
infect
lri
especi
extrem
age
season
distribut
occur
mainli
winter
spring
incub
period
usual
day
hmpv
wide
recogn
opportunist
infect
immunocompromis
host
hematopoiet
stem
cell
transplant
hsct
pulmonari
transplant
recipi
lead
signific
respiratori
morbid
although
detect
yet
routin
perform
hmpv
appear
account
acut
pneumonia
patient
haematolog
malign
includ
hsct
similar
proport
rsv
rate
close
report
lung
transplant
recipi
rang
lri
contrast
seldom
report
sot
set
renal
transplant
patient
histori
kidney
transplant
sever
amyloidosi
refer
centr
dinfectiologi
necker
pasteur
acut
fever
day
year
transplant
treat
graft
reject
corticosteroid
clinic
cours
unev
except
recurr
prostat
current
immunosuppress
regimen
consist
mycophenol
mofetil
except
sore
throat
rhinorrhea
biolog
analys
show
elev
creactiv
protein
blood
level
mgl
normal
mgl
normal
blood
leukocyt
neutrophil
count
blood
lymphocyt
count
low
gl
cell
account
total
lymphocyt
gl
hiv
serolog
neg
blood
urin
cultur
steril
initi
chest
radiograph
normal
nonproduct
cough
without
dyspnea
chest
pain
appear
day
hospit
oxygen
satur
ambient
air
chest
auscult
normal
cough
increas
thorac
comput
tomographi
ct
scan
perform
day
reveal
bilater
ground
glass
infiltr
mainli
locat
subpleur
peripher
area
associ
bilater
pleural
effus
figur
mediastin
adenopathi
seen
clinic
radiolog
present
suggest
pneumocysti
jirovecii
pneumonia
trimethoprimsulfamethoxazol
initi
day
nasopharyng
aspir
screen
direct
immunofluoresc
specif
monoclon
antibodi
rsv
influenza
viru
b
piv
adenoviru
hmpv
verniol
franc
day
immunofluoresc
strongli
posit
hmpv
neg
virus
blood
cultur
pneumonia
l
pneumophila
urinari
antigen
detect
neg
pneumocysti
pneumonia
initi
suspect
bronchoalveolar
lavag
bal
fluid
analysi
perform
day
demonstr
cellsml
macrophag
neutrophil
lymphocyt
microbiolog
studi
reveal
bacteri
fungal
microorgan
gomorigrocott
stain
pneumocysti
jiroveci
detect
indirect
immunofluoresc
polymeras
chain
reaction
pcr
p
jiroveci
neg
hmpv
also
detect
bal
fluid
direct
immunofluoresc
microbiolog
investig
neg
except
hmpv
antibiot
discontinu
respiratori
symptom
spontan
improv
within
day
thu
decreas
immunosuppress
medic
ribavirin
intraven
immunoglobulin
consid
patient
discharg
day
second
hmpv
pneumonia
kidneytranspl
recipi
describ
literatur
first
report
case
sever
lri
requir
transient
intens
care
unit
stay
occur
three
year
kidney
transplant
receiv
immunosuppress
regimen
consist
ciclosporin
mg
bid
azathioprin
mgd
prednison
mgd
compar
case
patient
mild
symptom
mainli
cough
upper
respiratori
symptom
also
less
immunosuppress
without
corticosteroid
regimen
solid
organ
transplant
patient
hmpv
respons
lri
may
lead
hospit
signific
respiratori
ill
case
initi
clinic
symptom
nonspecif
thorac
ct
scan
help
chest
xray
less
sensit
consolid
nodular
infiltr
pleural
effus
may
seen
subpleur
basal
area
usual
observ
bilater
locat
seen
case
case
wherea
crazi
pave
network
smooth
linear
pattern
superimpos
area
groundglass
opac
unusu
bronchiectasi
common
seri
wong
et
al
note
lymphopenia
notic
patient
common
featur
report
hsct
patient
hmpv
account
patient
one
seri
illustr
although
innat
immun
respons
stimul
upon
hmpv
exposur
adapt
immun
also
appear
import
control
hmpv
paramyxovirus
matrix
protein
involv
induct
proinflammatori
respons
dendrit
cell
macrophag
ie
product
inflamm
may
caus
diffus
alveolar
damag
hyalin
membran
format
shown
histopatholog
investig
apart
respiratori
viral
infect
occur
sot
recipi
differenti
diagnos
hmpvassoci
lri
includ
sever
bacteri
fungal
pneumon
particularli
pneumocysti
pneumonia
ribavirin
previous
shown
activ
mous
model
infect
suggest
potenti
antivir
therapi
hsct
lung
transplant
recipi
hmpvassoci
lri
case
case
literatur
ribavirin
use
diagnosi
made
retrospect
patient
spontan
clinic
improv
conclus
hmpv
consid
potenti
caus
lri
kidney
transplant
recipi
may
mimic
pneumocysti
pneumonia
prompt
recognit
would
avoid
antibiot
use
diagnost
studi
bronchoscopi
earli
detect
use
immunofluoresc
andor
rtpcr
must
propos
routin
transplant
set
addit
earli
recognit
could
improv
implement
appropri
infect
control
practic
prevent
viral
spread
potenti
lifethreaten
infect
immunocompromis
patient
